Thanks EMAN. We know the patented IP is extensive. I was thinking kind of a "big picture" that INO has two distinctly separate platforms that are marketable. Many biotechs are chasing after a "one trick pony" and we have two huge and potentially all encompassing technologies. Why buy a race horse when you can buy two entire stables; trainers and owners included. EPIC year is upon us. Thanks for all of your insight EMAN. GLT longs...
I thought of that immediately when researching the SynCon platform!! I didn't mention it because I didn't want to seem like a pumper and also wanted to establish my position over the past 3 weeks. I've been sleeping very well since selling positions in two other stocks and putting the funds in INO. Feeling very comfortable with this investment!!